She was barely in her teens when a novelty song made her a household name. At 60, Sharon Cuneta remains a defining figure ...
People protecting themselves against a common virus might also be reducing their risk of developing dementia, it has been found. Researchers from Cardiff University, Stanford University, and the ...
An Alzheimer’s drug which has been rejected for NHS use can slow disease progression by eight years, researchers have claimed. Lecanemab has been licensed for use in the UK, but will not be made ...
Some blood markers associated with Alzheimer’s increased nearly twice as fast among people with obesity compared to people who didn't have obesity, according to results presented today at the ...
The shingles vaccine not only offers protection against the painful viral infection, a new study suggests that the two-dose shot also may slow the progression of dementia. Shingles, caused by the ...
An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk ...
South County Health says potential partnership would allow it to remain independent South County Health has announced a new partnership.The system has entered a 120-day exclusive diligence period to ...
Forever ensnared in a love-fued between 1800s literature and modern gaming, Eman Fatima tries her best to appease both her hobbies by tapping away at her keyboard and writing about her favorite games ...
An experimental gene therapy was found to slow the progression of Huntington’s disease in a “pivotal” Phase 1/2 study, according to drugmaker uniQure, marking a major step toward a potential first ...
The beauty of Android's operating system lies in its ability to be customized and tailored to your preferences. You can switch your default launcher and change how the icon appears on your Android ...
CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death ...